ROCÍO
GARCÍA CARBONERO
Profesora asociada de Ciencias de la Salud
Hospital Morales Meseguer
Murcia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Morales Meseguer (13)
2023
-
Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin
Nature Communications, Vol. 14, Núm. 1
-
SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)
Clinical and Translational Oncology, Vol. 25, Núm. 9, pp. 2692-2706
2022
-
External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU Study
Neuroendocrinology, Vol. 112, Núm. 1, pp. 88-100
-
Position Statement on the Diagnosis, Treatment, and Response Evaluation to Systemic Therapies of Advanced Neuroendocrine Tumors, With a Special Focus on Radioligand Therapy
The oncologist, Vol. 27, Núm. 4, pp. e328-e339
2021
-
Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM)
ESMO Open, Vol. 6, Núm. 2
-
Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus
Pancreatology, Vol. 21, Núm. 1, pp. 215-223
2019
-
Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study)
British Journal of Cancer, Vol. 121, Núm. 7, pp. 537-544
-
Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 37, Núm. 28, pp. 2571-2580
2018
-
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)
Oncologist, Vol. 23, Núm. 4, pp. 422-432
2017
-
Optimizing somatostatin analog use in well or moderately differentiated gastroenteropancreatic neuroendocrine tumors
Current Oncology Reports, Vol. 19, Núm. 11
-
SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer
Clinical and Translational Oncology, Vol. 19, Núm. 2, pp. 135-148
2015
-
Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors
Cancer and Metastasis Reviews, Vol. 34, Núm. 3, pp. 381-400
-
Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development
Cancer and Metastasis Reviews, Vol. 34, Núm. 4, pp. 823-842